Cite
HARVARD Citation
Watson-Jones, D. et al. (2022). Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial. Lancet. 10 (10), pp. e1473-e1484. [Online].